In conclusion, this study demonstrated that loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer, which may provide a promising therapeutic strategy for advanced CRCs. The gene discussed is ZG16; the disease is colorectal cancer.